Erratum: A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage (Oncogene (2016) 35 (22-34) DOI: 10.1038/onc.2015.68);A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage

Oncogene

Volumn 35, Issue 1, 2016, Pages 22-34

  Chen, X ^a   Bosques, L ^a   Sung, P ^a   Kupfer, G M ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CYCLINE; DNA; DNA POLYMERASE; FANCONI ANEMIA GROUP D2 PROTEIN; HYDROXYUREA; MITOMYCIN; PROTEIN POLH; RAD18 PROTEIN; RAD51 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; DNA DIRECTED DNA POLYMERASE; DNA DIRECTED DNA POLYMERASE ETA; FANCD2 PROTEIN, HUMAN; RAD18 PROTEIN, HUMAN; RAD51 PROTEIN, HUMAN;

ARTICLE; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; GENE SILENCING; HOMOLOGOUS RECOMBINATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; S PHASE CELL CYCLE CHECKPOINT; UBIQUITINATION; DEFICIENCY; FANCONI ANEMIA; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM;

DNA DAMAGE; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; HYDROXYUREA; PROLIFERATING CELL NUCLEAR ANTIGEN; RAD51 RECOMBINASE; UBIQUITINATION;

EID: 84954386307     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2017.238     Document Type: Erratum

References (50)

1. Kim H, D'Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 2012; 26: 1393-1408.
2. Green AM, Kupfer GM. Fanconi anemia. Hematol Oncol Clin North Am 2009; 23: 193-214.
3. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007; 8: 735-748.
4. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol 2006; 43: 147-156.
5. Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia Blood 2013; 123: 26-34.
6. Pickering A, Zhang J, Panneerselvam J, Fei P. Advances in the understanding of Fanconi anemia tumor suppressor pathway. Cancer Biol Ther 2013; 14: 1089-1091.
7. Alpi AF, Patel KJ. Monoubiquitylation in the Fanconi anemia DNA damage response pathway. DNA Repair 2009; 8: 430-435.
8. Holloman WK. Unraveling the mechanism of BRCA2 in homologous recombination. Nat Struct Mol Biol 2011; 18: 748-754.
9. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297: 606-609.
10. Lehmann AR, Niimi A, Ogi T, Brown S, Sabbioneda S, Wing JF et al. Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair 2007; 6: 891-899.
11. Chang DJ, Cimprich KA. DNA damage tolerance: when it's OK to make mistakes. Nat Chem Biol 2009; 5: 82-90.
12. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M et al. Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J 2004; 23: 3886-3896.
13. Williams SA, Longerich S, Sung P, Vaziri C, Kupfer GM. The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI. Blood 2011; 117: 5078-5087.
14. Howlett NG, Harney JA, Rego MA, Kolling FWt, Glover TW. Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. J Biol Chem 2009; 284: 28935-28942.
15. Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S et al. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genet 2004; 13: 1241-1248.
16. Nijman SM, Huang TT, Dirac AM, Brummelkamp TR, Kerkhoven RM, D'Andrea AD et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell 2005; 17: 331-339.
17. Huang TT, Nijman SM, Mirchandani KD, Galardy PJ, Cohn MA, Haas W et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol 2006; 8: 339-347.
18. Palle K, Vaziri C. Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition. Cell Cycle 2011; 10: 1625-1638.
19. Mirchandani KD, McCaffrey RM, D'Andrea AD. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair 2008; 7: 902-911.
20. Knipscheer P, Raschle M, Smogorzewska A, Enoiu M, Ho TV, Scharer OD et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand crosslink repair. Science 2009; 326: 1698-1701.
21. Fu D, Dudimah FD, Zhang J, Pickering A, Paneerselvam J, Palrasu M et al. Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage. Cell Cycle 2013; 12: 803-809.
22. Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet 2005; 14: 693-701.
23. McCabe KM, Hemphill A, Akkari Y, Jakobs PM, Pauw D, Olson SB et al. ERCC1 is required for FANCD2 focus formation. Mol Genet Metab 2008; 95: 66-73.
24. Dunn J, Potter M, Rees A, Runger TM. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. Cancer Res 2006; 66: 11140-11147.
25. Tanaka T, Huang X, Halicka HD, Zhao H, Traganos F, Albino AP et al. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A 2007; 71: 648-661.
26. Koc A, Wheeler LJ, Mathews CK, Merrill GF. Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools. J Biol Chem 2004; 279: 223-230.
27. Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 2012; 22: 106-116.
28. Chaudhury I, Sareen A, Raghunandan M, Sobeck A. FANCD2 regulates BLM complex functions independently of FANCI to promote replication fork recovery. Nucleic Acids Res 2013; 41: 6444-6459.
29. Lossaint G, Larroque M, Ribeyre C, Bec N, Larroque C, Decaillet C et al. FANCD2 binds MCM proteins and controls replisome function upon activation of S phase checkpoint signaling. Mol Cell 2013; 51: 678-690.
30. Suhasini AN, Rawtani NA, Wu Y, Sommers JA, Sharma S, Mosedale G et al. Interaction between the helicases genetically linked to Fanconi anemia group J and Bloom's syndrome. EMBO J 2011; 30: 692-705.
31. Johnstone P, Reifsteck C, Kohler S, Worland P, Olson S, Moses RE et al. Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation. Somat Cell Mol Genet 1997; 23: 371-377.
32. Maurer-Schultze B, Siebert M, Bassukas ID. An in vivo study on the synchronizing effect of hydroxyurea. Exp Cell Res 1988; 174: 230-243.
33. Miyase S, Tateishi S, Watanabe K, Tomita K, Suzuki K, Inoue H et al. Differential regulation of Rad18 through Rad6-dependent mono-and polyubiquitination. J Biol Chem 2005; 280: 515-524.
34. Zeman MK, Lin JR, Freire R, Cimprich KA. DNA damage-specific deubiquitination regulates Rad18 functions to suppress mutagenesis. J Cell Biol 2014; 206: 183-197.
35. Brown S, Niimi A, Lehmann AR. Ubiquitination and deubiquitination of PCNA in response to stalling of the replication fork. Cell Cycle 2009; 8: 689-692.
36. Chen J, Bozza W, Zhuang Z. Ubiquitination of PCNA and its essential role in eukaryotic translesion synthesis. Cell Biochem Biophys 2011; 60: 47-60.
37. Terai K, Abbas T, Jazaeri AA, Dutta A. CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Mol Cell 2010; 37: 143-149.
38. Bindra RS, Goglia AG, Jasin M, Powell SN. Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells. Nucleic Acids Res 2013; 41: e115.
39. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002; 419: 135-141.
40. Stelter P, Ulrich HD. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 2003; 425: 188-191.
41. Kannouche PL, Lehmann AR. Ubiquitination of PCNA and the polymerase switch in human cells. Cell Cycle 2004; 3: 1011-1013.
42. Moldovan GL, Dejsuphong D, Petalcorin MI, Hofmann K, Takeda S, Boulton SJ et al. Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol Cell 2012; 45: 75-86.
43. Lin JR, Zeman MK, Chen JY, Yee MC, Cimprich KA. SHPRH and HLTF act in a damage-specific manner to coordinate different forms of postreplication repair and prevent mutagenesis. Mol Cell 2011; 42: 237-249.
44. Williams SA, Wilson JB, Clark AP, Mitson-Salazar A, Tomashevski A, Ananth S et al. Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet 2011; 20: 4395-4410.
45. Hirano S, Yamamoto K, Ishiai M, Yamazoe M, Seki M, Matsushita N et al. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J 2005; 24: 418-427.
46. Reliene R, Yamamoto ML, Rao PN, Schiestl RH. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg. Cancer Res 2010; 70: 9703-9710.
47. Ho TV, Scharer OD, Translesion DNA. synthesis polymerases in DNA interstrand crosslink repair. Environ Mol Mutagen 2010; 51: 552-566.
48. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD et al. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci USA 2005; 102: 1110-1115.
49. Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell 2010; 37: 492-502.
50. Qiao F, Moss A, Kupfer GM. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage-and cell cycle-regulated manner. J Biol Chem 2001; 276: 23391-23396.